Can vaccines cause alpha‑gal (galactose‑α‑1,3‑galactose) sensitization or trigger an alpha‑gal allergy?

Can Vaccines Cause Alpha-Gal Syndrome?

Vaccines do not cause alpha-gal sensitization, but certain gelatin-containing vaccines can trigger severe allergic reactions, including anaphylaxis, in patients who are already sensitized to alpha-gal through tick bites.

Understanding the Mechanism

Alpha-gal (galactose-α-1,3-galactose) sensitization occurs primarily through tick bites, not through vaccines 1, 2, 3. The tick saliva introduces the alpha-gal epitope and triggers the immune system to produce IgE antibodies against this carbohydrate. Vaccines are a trigger for reactions in already-sensitized individuals, not the cause of sensitization.

Which Vaccines Contain Alpha-Gal

Certain vaccines contain hydrolyzed gelatin derived from bovine or porcine sources, which contains alpha-gal 4, 5, 4. The vaccines of concern include:

• MMR (measles, mumps, rubella) vaccine
• MMRV (measles, mumps, rubella, varicella) vaccine
• Varicella (chickenpox) vaccine
• Zoster (shingles) vaccine
• Rabies vaccine (some formulations)

These vaccines use gelatin as a stabilizer and may contain bovine calf serum, both of which are sources of alpha-gal 1, 6.

Clinical Evidence

Research demonstrates that gelatin-containing vaccines activate basophils in patients with established alpha-gal syndrome 6. A 2017 case report documented anaphylaxis after zoster vaccine in an alpha-gal allergic patient, with subsequent testing confirming alpha-gal presence in MMR and zoster vaccines 1. A 2025 study from the Indian subcontinent reported 6 patients with alpha-gal syndrome who developed allergic reactions, including anaphylaxis, to MMR, rubella, varicella, and rabies vaccines 2.

Importantly, non-gelatin formulations of MMR vaccine did not trigger basophil activation in alpha-gal patients 6, confirming that the gelatin component—not the vaccine antigens themselves—is the culprit.

Critical Distinction from Other Vaccine Allergies

The ACIP guidelines extensively discuss vaccine component allergies but focus on egg protein (in influenza and yellow fever vaccines) and gelatin allergies as separate entities 5, 4, 5. The guidelines note that rare serious allergic reactions after MMR vaccination are believed to be caused by gelatin rather than egg antigens 4, 5, 7. However, these older guidelines (2002-2006) predate the recognition of alpha-gal syndrome and do not specifically address alpha-gal as the mechanism behind gelatin-related reactions.

Clinical Management Algorithm

For Patients WITHOUT Known Alpha-Gal Syndrome:

• Administer gelatin-containing vaccines per standard protocols
• Screen for history of delayed reactions to red meat (2-8 hours post-ingestion)
• If delayed meat allergy suspected, test for alpha-gal IgE before vaccination

For Patients WITH Confirmed Alpha-Gal Syndrome:

1. Avoid gelatin-containing vaccines when possible 8, 9
2. Use non-gelatin formulations when available (e.g., certain MMR formulations) 6
3. If gelatin-containing vaccine is essential:
   • Consult with allergist
   • Have epinephrine autoinjector available
   • Administer in monitored setting with resuscitation equipment
   • Observe for extended period (reactions may be delayed)
   • Consider premedication with antihistamines and corticosteroids, though efficacy is unproven 9

For Patients with History of Anaphylaxis to Gelatin:

• Extreme caution required per ACIP guidelines 4, 5
• Skin testing for gelatin sensitivity can be considered, though no standardized protocols exist 4, 5
• Referral to allergist is mandatory 8

Common Pitfalls to Avoid

1. Confusing causation with triggering: Vaccines trigger reactions in sensitized patients but do not cause the initial sensitization
2. Overlooking tick bite history: Always ask about tick exposure in patients with unexplained anaphylaxis or delayed food reactions 2, 10
3. Assuming all MMR vaccines are identical: Some formulations contain gelatin while others do not 6
4. Missing the diagnosis: Alpha-gal syndrome should be considered in patients with urticaria or anaphylaxis of uncertain origin, especially after vaccine administration 10

Geographic Considerations

Alpha-gal syndrome is increasingly recognized globally, with cases documented in the US (particularly southeastern states), Europe, Australia, Japan, South Korea, and the Indian subcontinent 2, 3, 11. The geographic distribution follows tick populations, particularly the Lone Star tick in North America 9. With climate change expanding tick ranges, more patients will be affected 3.

Additional Alpha-Gal Sources in Medical Products

Beyond vaccines, alpha-gal is present in other medical products that may cause reactions in sensitized patients 8, 9:

• Cetuximab (monoclonal antibody)
• Certain intravenous medications containing gelatin
• Biological heart valves (bovine or porcine)
• Plasma expanders
• Anti-venom products

Healthcare providers should review medication ingredients carefully for patients with alpha-gal syndrome 8, 12.